2-61825326-T-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001201543.2(FAM161A):​c.*1129A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00396 in 454,190 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0035 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 6 hom. )

Consequence

FAM161A
NM_001201543.2 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.181

Publications

0 publications found
Variant links:
Genes affected
FAM161A (HGNC:25808): (FAM161 centrosomal protein A) This gene belongs to the FAM161 family. It is expressed mainly in the retina. Mouse studies suggested that this gene is involved in development of retinal progenitors during embryogenesis, and that its activity is restricted to mature photoreceptors after birth. Mutations in this gene cause autosomal recessive retinitis pigmentosa-28. Alternatively spliced transcript variants have been identified.[provided by RefSeq, Jan 2011]
FAM161A Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0035 (533/152262) while in subpopulation AMR AF = 0.00562 (86/15296). AF 95% confidence interval is 0.00466. There are 4 homozygotes in GnomAd4. There are 300 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM161ANM_001201543.2 linkc.*1129A>C 3_prime_UTR_variant Exon 7 of 7 ENST00000404929.6 NP_001188472.1 Q3B820-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM161AENST00000404929.6 linkc.*1129A>C 3_prime_UTR_variant Exon 7 of 7 1 NM_001201543.2 ENSP00000385158.1 Q3B820-3

Frequencies

GnomAD3 genomes
AF:
0.00350
AC:
533
AN:
152144
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0156
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00292
AC:
381
AN:
130622
AF XY:
0.00299
show subpopulations
Gnomad AFR exome
AF:
0.000164
Gnomad AMR exome
AF:
0.00251
Gnomad ASJ exome
AF:
0.00296
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0162
Gnomad NFE exome
AF:
0.00338
Gnomad OTH exome
AF:
0.00275
GnomAD4 exome
AF:
0.00419
AC:
1265
AN:
301928
Hom.:
6
Cov.:
0
AF XY:
0.00398
AC XY:
685
AN XY:
172068
show subpopulations
African (AFR)
AF:
0.000117
AC:
1
AN:
8554
American (AMR)
AF:
0.00260
AC:
71
AN:
27272
Ashkenazi Jewish (ASJ)
AF:
0.00287
AC:
31
AN:
10786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9348
South Asian (SAS)
AF:
0.00104
AC:
62
AN:
59650
European-Finnish (FIN)
AF:
0.0195
AC:
241
AN:
12364
Middle Eastern (MID)
AF:
0.000870
AC:
1
AN:
1150
European-Non Finnish (NFE)
AF:
0.00501
AC:
795
AN:
158762
Other (OTH)
AF:
0.00449
AC:
63
AN:
14042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
79
159
238
318
397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00350
AC:
533
AN:
152262
Hom.:
4
Cov.:
32
AF XY:
0.00403
AC XY:
300
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41558
American (AMR)
AF:
0.00562
AC:
86
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4820
European-Finnish (FIN)
AF:
0.0156
AC:
165
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68020
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00302
Hom.:
1
Bravo
AF:
0.00227
Asia WGS
AF:
0.000579
AC:
2
AN:
3468

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Retinitis pigmentosa Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.7
DANN
Benign
0.57
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76144251; hg19: chr2-62052461; API